menu
    • menu

    Company profile for AEON Biopharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AEON Biopharma is a bio-pharmaceutical company focused on developing a proprietary 900 kDabotulinum toxin complex, ABP-450, for debilitating medical conditions. We are committed to developing novel and proprietary treatment paradigms to improve patient outcomes and drive enhanced value to patients, physicians, and payers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AEON BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4040 MACARTHUR BL. SUITE 260 NEWPORT BEACH, California 92660, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aeonbiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AEON Bio: First PIPE Investment Close, FDA Type 2A Meeting Update
    AEON Bio: First PIPE Investment Close, FDA Type 2A Meeting Update

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191914/0/en/AEON-Biopharma-Announces-First-Closing-of-PIPE-Investment-and-Provides-Update-on-FDA-Type-2a-Meeting-Scheduling.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    AEON Bio Reports Q3 2025 Results With ABP-450 Biosimilarity
    AEON Bio Reports Q3 2025 Results With ABP-450 Biosimilarity

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188319/0/en/AEON-Biopharma-Reports-Third-Quarter-2025-Results-Including-Positive-ABP-450-Biosimilarity-Data-and-Strategic-Positioning-for-Continued-Growth.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    AEON Bio Raises ~$22M Via Private Placement And Daewoong Notes
    AEON Bio Raises ~$22M Via Private Placement And Daewoong Notes

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187343/0/en/AEON-Biopharma-Announces-Fundraise-Totaling-Up-to-22-Million-through-Private-Placement-and-Proposed-Exchange-of-Daewoong-Convertible-Notes.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    AEON Biopharma Confirms Identical Amino Acid Sequences
    AEON Biopharma Confirms Identical Amino Acid Sequences

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187363/0/en/AEON-Biopharma-Reports-Positive-and-Robust-Biosimilarity-Results-Identical-Amino-Acid-Sequence-and-Highly-Similar-Functional-Analysis-Data.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Aeon Bio To Hold FDA Bpd Type 2a Meeting For Abp-450 On Nov 19
    Aeon Bio To Hold FDA Bpd Type 2a Meeting For Abp-450 On Nov 19

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159473/0/en/AEON-Biopharma-Announces-FDA-BPD-Type-2a-Meeting-for-ABP-450-on-November-19.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    AEON Biopharma Q2 2025 Financial Results and Corporate Update
    AEON Biopharma Q2 2025 Financial Results and Corporate Update

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3132104/0/en/AEON-Biopharma-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search